Sirnaomics Ltd. (HKG:2257)

Market Cap	455.20M -56.2%
Revenue (ttm)	250.95K -96.6%
Net Income	-83.24M
EPS	-0.86
Shares Out	108.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,450
Open	4.185
Previous Close	4.200
Day's Range	4.050 - 4.185
52-Week Range	3.550 - 10.720
Beta	-0.07
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 18, 2026

About Sirnaomics

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People’s Republic of China. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates comprising STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; STP369 to treat head and neck cancer; and STP707 and STP355 to treat solid tumo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 37
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2257

Financial Performance

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 3, 2026

Data Sources Report a data error